Cargando…

Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults

BACKGROUND: Gaze abnormality is a diagnostic criterion for autism spectrum disorder (ASD). However, few easy-to-use clinical tools exist to evaluate the unique eye-gaze patterns of ASD. Recently, we developed Gazefinder, an all-in-one eye-tracking system for early detection of ASD in toddlers. Becau...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujioka, Toru, Inohara, Keisuke, Okamoto, Yuko, Masuya, Yasuhiro, Ishitobi, Makoto, Saito, Daisuke N., Jung, Minyoung, Arai, Sumiyoshi, Matsumura, Yukiko, Fujisawa, Takashi X., Narita, Kosuke, Suzuki, Katsuaki, Tsuchiya, Kenji J., Mori, Norio, Katayama, Taiichi, Sato, Makoto, Munesue, Toshio, Okazawa, Hidehiko, Tomoda, Akemi, Wada, Yuji, Kosaka, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804639/
https://www.ncbi.nlm.nih.gov/pubmed/27011784
http://dx.doi.org/10.1186/s13229-016-0083-y
_version_ 1782423059587661824
author Fujioka, Toru
Inohara, Keisuke
Okamoto, Yuko
Masuya, Yasuhiro
Ishitobi, Makoto
Saito, Daisuke N.
Jung, Minyoung
Arai, Sumiyoshi
Matsumura, Yukiko
Fujisawa, Takashi X.
Narita, Kosuke
Suzuki, Katsuaki
Tsuchiya, Kenji J.
Mori, Norio
Katayama, Taiichi
Sato, Makoto
Munesue, Toshio
Okazawa, Hidehiko
Tomoda, Akemi
Wada, Yuji
Kosaka, Hirotaka
author_facet Fujioka, Toru
Inohara, Keisuke
Okamoto, Yuko
Masuya, Yasuhiro
Ishitobi, Makoto
Saito, Daisuke N.
Jung, Minyoung
Arai, Sumiyoshi
Matsumura, Yukiko
Fujisawa, Takashi X.
Narita, Kosuke
Suzuki, Katsuaki
Tsuchiya, Kenji J.
Mori, Norio
Katayama, Taiichi
Sato, Makoto
Munesue, Toshio
Okazawa, Hidehiko
Tomoda, Akemi
Wada, Yuji
Kosaka, Hirotaka
author_sort Fujioka, Toru
collection PubMed
description BACKGROUND: Gaze abnormality is a diagnostic criterion for autism spectrum disorder (ASD). However, few easy-to-use clinical tools exist to evaluate the unique eye-gaze patterns of ASD. Recently, we developed Gazefinder, an all-in-one eye-tracking system for early detection of ASD in toddlers. Because abnormal gaze patterns have been documented in various ASD age groups, we predicted that Gazefinder might also detect gaze abnormality in adolescents and adults. In this study, we tested whether Gazefinder could identify unique gaze patterns in adolescents and adults with ASD. METHODS: We measured the percentage of eye fixation time allocated to particular objects depicted in movies (i.e., eyes and mouth in human face movies, upright and inverted biological motion in movies that presented these stimuli simultaneously, and people and geometry in movies that presented these stimuli simultaneously) by male adolescents and adults with ASD (N = 26) and age-matched males with typical development (TD; N = 35). We compared these percentages between the two groups (ASD and TD) and with scores on the social responsiveness scale (SRS). Further, we conducted discriminant analyses to determine if fixation times allocated to particular objects could be used to discriminate between individuals with and without ASD. RESULTS: Compared with the TD group, the ASD group showed significantly less fixation time at locations of salient social information (i.e., eyes in the movie of human faces without lip movement and people in the movie of people and geometry), while there were no significant groupwise differences in the responses to movies of human faces with lip movement or biological motion. In a within-group correlation analysis, a few of the fixation-time items correlated with SRS, although most of them did not. No items significantly correlated with SRS in both ASD and TD groups. The percentage fixation times to eyes and people, which exhibited large effect sizes for the group difference, could differentiate ASD and TD with a sensitivity of 81.0 % and a specificity of 80.0 %. CONCLUSIONS: These findings suggest that Gazefinder is potentially a valuable and easy-to-use tool for objectively measuring unique gaze patterns and discriminating between ASD and TD in male adolescents and adults. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13229-016-0083-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4804639
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48046392016-03-24 Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults Fujioka, Toru Inohara, Keisuke Okamoto, Yuko Masuya, Yasuhiro Ishitobi, Makoto Saito, Daisuke N. Jung, Minyoung Arai, Sumiyoshi Matsumura, Yukiko Fujisawa, Takashi X. Narita, Kosuke Suzuki, Katsuaki Tsuchiya, Kenji J. Mori, Norio Katayama, Taiichi Sato, Makoto Munesue, Toshio Okazawa, Hidehiko Tomoda, Akemi Wada, Yuji Kosaka, Hirotaka Mol Autism Research BACKGROUND: Gaze abnormality is a diagnostic criterion for autism spectrum disorder (ASD). However, few easy-to-use clinical tools exist to evaluate the unique eye-gaze patterns of ASD. Recently, we developed Gazefinder, an all-in-one eye-tracking system for early detection of ASD in toddlers. Because abnormal gaze patterns have been documented in various ASD age groups, we predicted that Gazefinder might also detect gaze abnormality in adolescents and adults. In this study, we tested whether Gazefinder could identify unique gaze patterns in adolescents and adults with ASD. METHODS: We measured the percentage of eye fixation time allocated to particular objects depicted in movies (i.e., eyes and mouth in human face movies, upright and inverted biological motion in movies that presented these stimuli simultaneously, and people and geometry in movies that presented these stimuli simultaneously) by male adolescents and adults with ASD (N = 26) and age-matched males with typical development (TD; N = 35). We compared these percentages between the two groups (ASD and TD) and with scores on the social responsiveness scale (SRS). Further, we conducted discriminant analyses to determine if fixation times allocated to particular objects could be used to discriminate between individuals with and without ASD. RESULTS: Compared with the TD group, the ASD group showed significantly less fixation time at locations of salient social information (i.e., eyes in the movie of human faces without lip movement and people in the movie of people and geometry), while there were no significant groupwise differences in the responses to movies of human faces with lip movement or biological motion. In a within-group correlation analysis, a few of the fixation-time items correlated with SRS, although most of them did not. No items significantly correlated with SRS in both ASD and TD groups. The percentage fixation times to eyes and people, which exhibited large effect sizes for the group difference, could differentiate ASD and TD with a sensitivity of 81.0 % and a specificity of 80.0 %. CONCLUSIONS: These findings suggest that Gazefinder is potentially a valuable and easy-to-use tool for objectively measuring unique gaze patterns and discriminating between ASD and TD in male adolescents and adults. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13229-016-0083-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-23 /pmc/articles/PMC4804639/ /pubmed/27011784 http://dx.doi.org/10.1186/s13229-016-0083-y Text en © Fujioka et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Fujioka, Toru
Inohara, Keisuke
Okamoto, Yuko
Masuya, Yasuhiro
Ishitobi, Makoto
Saito, Daisuke N.
Jung, Minyoung
Arai, Sumiyoshi
Matsumura, Yukiko
Fujisawa, Takashi X.
Narita, Kosuke
Suzuki, Katsuaki
Tsuchiya, Kenji J.
Mori, Norio
Katayama, Taiichi
Sato, Makoto
Munesue, Toshio
Okazawa, Hidehiko
Tomoda, Akemi
Wada, Yuji
Kosaka, Hirotaka
Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
title Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
title_full Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
title_fullStr Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
title_full_unstemmed Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
title_short Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
title_sort gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804639/
https://www.ncbi.nlm.nih.gov/pubmed/27011784
http://dx.doi.org/10.1186/s13229-016-0083-y
work_keys_str_mv AT fujiokatoru gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT inoharakeisuke gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT okamotoyuko gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT masuyayasuhiro gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT ishitobimakoto gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT saitodaisuken gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT jungminyoung gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT araisumiyoshi gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT matsumurayukiko gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT fujisawatakashix gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT naritakosuke gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT suzukikatsuaki gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT tsuchiyakenjij gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT morinorio gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT katayamataiichi gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT satomakoto gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT munesuetoshio gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT okazawahidehiko gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT tomodaakemi gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT wadayuji gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults
AT kosakahirotaka gazefinderasaclinicalsupplementarytoolfordiscriminatingbetweenautismspectrumdisorderandtypicaldevelopmentinmaleadolescentsandadults